Top Story

PUBLICATION EXCLUSIVE: Descemet's membrane endothelial keratoplasty slowly on the rise

July 23, 2017

Lamellar techniques have almost entirely replaced penetrating keratoplasty. They have undergone progressive refinements and have more recently evolved toward minimizing the presence of allogenic tissue in the eye to prevent rejection and graft failure.

“Overall, if we can work toward smaller grafts or no graft at all, this is going to benefit the patient in many ways. On the other hand, if we can multiply the number of grafts we can obtain from the same donor, we can reduce the costs and the problem of tissue shortage in some areas of the world,” Gerrit Melles, MD, PhD, said.


BLOG: Three reasons cornea is the new glaucoma

July 22, 2017
Ophthalmology is a great specialty partly because procedures, devices and drugs constantly evolve, keeping us learning and giving our patients better care. Ask your…

Alimera allowed to reduce size of Iluvien study in UK

July 21, 2017
The United Kingdom’s Medicines and Healthcare Products Regulatory Agency has given final approval to reduce the size of Alimera Sciences’ post-marketing…

Voretigene neparvovec receives rare pediatric disease designation from FDA

July 21, 2017
The FDA offices of Orphan Products Development and Pediatric Therapeutics have designated voretigene neparvovec as a drug for a rare pediatric disease, according to a…

Akorn shareholders approve Fresenius Kabi merger

July 21, 2017
Akorn shareholders have approved a merger with Fresenius Kabi, according to an Akorn press release. Fresenius Kabi announced in April that it
More News Headlines »
Original Article

Regular Versus Releasable Sutures in Surgery for Primary Congenital Glaucoma

Journal of Pediatric Ophthalmology and Strabismus
Online Advanced Release, June 15, 2017
To compare releasable and regular sutures in combined angle and filtering surgery for primary congenital glaucoma. A…
More »

Non-infectious Uveitis: Moving Beyond the Standard of Care with an Eye on the Evidence

This activity is supported by educational grants from AbbVie, Inc.

Uveitis is one of the leading causes of preventable blindness worldwide with a prevalence in the US of about 38 cases…
More »
Resource Centers
Meeting News

VIDEO: SightLife Surgical begins growing endothelial cells in Seattle

June 28, 2017
More »